What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.5% in the afternoon session after the stock ...

Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

Moderna (MRNA) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.

Former firefighter John Knox's ties to RFK Jr. have landed him atop the agency that helped bring Covid-19 under control.

The American Heart Association updates recommendations for cardiac arrest, choking and overdose response, plus an unexpected ...

Researchers found that COVID-19 mRNA vaccines significantly increased survival in lung and skin cancer patients undergoing ...

Epidemiologist Dr. Seth Berkley spoke to Live Science about the importance of vaccine equity and the obstacles undermining it ...

President Donald Trump’s physician, Dr. Sean P. Barbabella, announced that after conducting a battery of tests, he found that ...

A new preliminary study published in Nature suggests that COVID-19 vaccines might actually boost the immune system to make ...

UNLV scientists successfully introduced nanoparticles with messenger RNA into the pancreas for the first time with 99% accuracy.